Company Filing History:
Years Active: 2019-2023
Title: The Innovative Contributions of Amy Freedman
Introduction
Amy Freedman is a notable inventor based in Yardley, Pennsylvania. She has made significant contributions to the field of therapeutic risk management, holding two patents that showcase her innovative spirit and dedication to improving patient care.
Latest Patents
Freedman's latest patents focus on a device-based risk management system (RMS) for therapeutic agents. The RMS device includes a comprehensive database and processor designed to streamline the enrollment of patients in therapeutic programs. The system features a prescriber module that receives requests to enroll patients, which include specifications of indications and confirmations of diagnostic tests. Additionally, the RMS processor generates patient profiles and stores them in the RMS database. An authorization module is also included, which generates codes to indicate whether patients are authorized to receive specific therapeutic agents. This innovative approach aims to enhance the efficiency and safety of therapeutic interventions.
Career Highlights
Amy Freedman is currently employed at Otsuka Pharmaceutical Company, Limited, where she continues to develop and refine her innovative ideas. Her work at Otsuka highlights her commitment to advancing healthcare solutions through technology and research.
Collaborations
Freedman collaborates with esteemed colleagues, including Frank S. Czerwiec and Keith Friend. These partnerships reflect her ability to work effectively within a team to drive innovation in the pharmaceutical industry.
Conclusion
Amy Freedman's contributions to therapeutic risk management exemplify her dedication to improving patient outcomes through innovative technology. Her patents and work at Otsuka Pharmaceutical Company, Limited, position her as a key figure in the field of healthcare innovation.